Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and ...

Experts convened in Cleveland, Ohio, on November 11, 2025, to discuss the evolution of cardio-renal-metabolic care from ...

Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of ...

In this video, Laura Aponte Becerra, MD, discusses promising results from the MIRO-CKD and the SURPASS-CVOT trials presented at ASN Kidney Week.“The take-home message across these two studies is that ...

Ziltivekimab, an anti-IL-6 ligand antibody, increases iron and other anemia parameters in patients with chronic kidney disease. Ziltivekimab, a novel anti-IL-6 ligand antibody, improves ...

A 1-year, multipart lifestyle intervention helped improve glycemic control and kidney function and reduce dependence on medication in patients with type 2 diabetes (T2D) at risk for chronic kidney ...

Targeting and disabling a certain protein essential to transporting glucose properly through cells (Glucose Transporter 1, or ...

WATERTOWN, Mass., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...

Unlike in the general population, women with stage 5 chronic kidney disease (CKD) do not have a sex-based survival advantage ...

People with diabetes have a higher risk of many different health issues, including kidney and heart problems. Although various medicines can help reduce the risk of these issues, many people with ...

A new study published in the American Journal of Physiology - Heart and Circulatory Physiology reveals that chronic kidney ...